(19)
(11) EP 4 281 048 A1

(12)

(43) Date of publication:
29.11.2023 Bulletin 2023/48

(21) Application number: 22702430.4

(22) Date of filing: 24.01.2022
(51) International Patent Classification (IPC): 
A61K 9/24(2006.01)
A61P 31/04(2006.01)
A61K 31/4178(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/209; A61K 31/4178; A61P 31/04
(86) International application number:
PCT/EP2022/051486
(87) International publication number:
WO 2022/157357 (28.07.2022 Gazette 2022/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.01.2021 EP 21153203

(71) Applicant: Adamed Pharma S.A.
05-152 Czosnow (PL)

(72) Inventors:
  • TRELA, Jolanta
    95-200 Pabianice (PL)
  • KUBIAK, Bartlomiej
    05-101 Nowy Dwor Mazowiecki (PL)
  • KIRYLUK, Anna
    05-800 Pruszkow (PL)
  • NIEMCZYK, Katarzyna
    32-600 Oswiecim (PL)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) PROLONGED-RELEASE FURAZIDIN COMPOSITION